ABCB4 p.Met301Thr

[switch to full view]
Comments [show]
Publications
PMID: 16622704 [PubMed] Oude Elferink RP et al: "Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein)."
No. Sentence Comment
141 Canalicular lipid transport defects can cause gallstone formation Cholesterol supersaturation of bile, which occurs in a large proportion of humans, leads to the formation of cholesterol Walker B; L556R 571del Truncation PFIC3 LPAC ICP 27 splice Truncation 132 del Truncation TM 2; W138R TM 12; 981 del Truncation Linker; Q636X Truncation TM 11; R957X Truncation TM 6; S346I E395G Walker B; I541F TM 12; G983S Walker A; V425M Walker A; T424A Walker B; D564G TM 7; F711S 180 del truncation 336 delT truncation Exon 22-23 del truncation F165I T175A TM 5; M301T TM 5; S320F 336 insT truncation Walker A; 432 insA truncation E528D L591Q W658stop 757 insT R788E A934T P1161S TM 5; S320F TM 8; G762ER144X Walker B; A546D Walker B; G535AALL 96 del Truncation Walker B; L556R 571del Truncation PFIC3 LPAC ICP 27 splice Truncation 132 del Truncation TM 2; W138R TM 12; 981 del Truncation Linker; Q636X Truncation TM 11; R957X Truncation TM 6; S346I E395G Walker B; I541F TM 12; G983S Walker A; V425M Walker A; T424A Walker B; D564G TM 7; F711S 180 del truncation 336 delT truncation Exon 22-23 del truncation F165I T175A TM 5; M301T TM 5; S320F 336 insT truncation Walker A; 432 insA truncation E528D L591Q W658stop 757 insT R788E A934T P1161S TM 5; S320F TM 8; G762ER144X Walker B; A546D Walker B; G535AALL 96 del Truncation Fig. 3 Summary of the known mutations and their localization in the protein, as identified in patients with PFIC type 3, LPAC syndrome (intrahepatic gallstone formation), and intrahepatic cholestasis of pregnancy (ICP).
X
ABCB4 p.Met301Thr 16622704:141:553
status: NEW
X
ABCB4 p.Met301Thr 16622704:141:1118
status: NEW
Login to comment

PMID: 12891548 [PubMed] Rosmorduc O et al: "ABCB4 gene mutation-associated cholelithiasis in adults."
No. Sentence Comment
68 ABCB4 Gene Mutations in Patients With LPAC Syndrome Gene position Location and nucleotide change Peptide change Protein domain Status 6 495T3A Phe165Ile First intracellular loop Heterozygous 523T3C Thr175Ala between TM2 and TM3 Heterozygous 9 902T3C Met301Thr TM5 Heterozygous 959C3T Ser320Phe TM5 Homozygous 10 1007-1015insT 355Stop TM6 Heterozygous 1007-1015delT 341Stop TM6 Heterozygous 12 1327insA 447Stop Close to NBD11 Heterozygous 14 1584G3C Glu528Asp Close to NBD11 Heterozygous 15 1772T3A Leu591Gln Third intracellular loop Homozygous 17 1973G3A Try658Stop Third intracellular loop linker domain Heterozygous 18 2270-2273insT 793Stop Fourth intracellular loop between TM8 and TM9 Heterozygous 19 2363G3T Arg788Glu Fourth intracellular loop between TM8 and TM9 Heterozygous 23 2800G3T Ala934Thr Fifth intracellular loop between TM10 and TM11 Homozygous 26 3481C3T Pro1161Ser Close to NBD2 Heterozygous NOTE. The A of ATG of the initiator Met codon was denoted as "nucleotide ϩ 1."
X
ABCB4 p.Met301Thr 12891548:68:250
status: NEW
Login to comment

PMID: 24381502 [PubMed] Kim TH et al: "Functional Characterization of ABCB4 Mutations Found in Low Phospholipid-Associated Cholelithiasis (LPAC)."
No. Sentence Comment
26 In this study, we selected 3 novel missense mutations of ABCB4 that were first reported by Rosmorduc et al. [3] and F165I 5`-AGG AAA TAG GAT GGA TTG ACA TCA ATG ACA-3` M301T 5`-GCA AAC ATT TCC ACG GGT ATT GCC TTS CTG-3` S320F 5`-AGG ACA CAA ATC AGA CAG CAT CAA AGG GAA-3` The SNP sites were marked by bold-faced letters with underlines.
X
ABCB4 p.Met301Thr 24381502:26:170
status: NEW
Login to comment

56 RESULTS Mutations of ABCB4 examined in this study To perform a molecular characterization of ABCB4 muta- cDNA position Amino acid substitution Predicted domain a c.495T&#ff1e;A F165I ICD1 c.902T&#ff1e;C M301T TM5 c.959C&#ff1e;T S320F TM5 Position of each mutant was based upon the translational start site.
X
ABCB4 p.Met301Thr 24381502:56:206
status: NEW
Login to comment

80 The ABCB4 mutant, F165I might be located in the ICD1, while other two mutants, M301T and S320F are located in the TM5 [3].
X
ABCB4 p.Met301Thr 24381502:80:79
status: NEW
Login to comment

84 To exclude ATPase activity by other endogenous ABC transporters including MDR1, values for transport activity were obtained by subtracting the uptake in empty vector-transfected cells from that in cells transfected with ABCB4 reference or mutant-bearing vectors, at each corresponding paclitaxel concentration. The uptake of paclitaxel Vmax (nmol mg &#ff0d;1 per min) Km (mM) Vmax/Km ratio (nmol mg&#ff0d;1 min &#ff0d;1 per mM) Reference 28.98&#b1;1.565 1.114&#b1;0.1391 27.13&#b1;5.232 F165I 16.82&#b1;1.565* 1.028&#b1;0.1189 15.56&#b1;4.658* M301T 23.23&#b1;0.8641 1.206&#b1;0.2875 20.60&#b1;5.628 S320F 18.55&#b1;2.726* 1.185&#b1;0.1064 15.99&#b1;3.736* Data (mean&#b1;SD) are from 5 separate experiments.
X
ABCB4 p.Met301Thr 24381502:84:546
status: NEW
Login to comment

93 M301T mutant also showed a reduction in the transport activity compared to that of the reference, although statistical significance was not observed.
X
ABCB4 p.Met301Thr 24381502:93:0
status: NEW
Login to comment

101 The MDR3 expression level of M301T was comparable with that of the reference.
X
ABCB4 p.Met301Thr 24381502:101:29
status: NEW
Login to comment

106 The subcellular expression of M301T was comparable with that of the reference while the co-localization of F165I and S320F with plasma membrane was decreased.
X
ABCB4 p.Met301Thr 24381502:106:30
status: NEW
Login to comment

117 M301T, showing a comparable transport activity with that of the reference is also located in TM5.
X
ABCB4 p.Met301Thr 24381502:117:0
status: NEW
Login to comment